Ishara Investments LP Concentrated Active

CIK: 0002111609 · Show all filings

Period: Q4 2025

Filing Date: Feb 17, 2026

Total Value ($000): $87,455 (100.0% shares, 0.0% debt)

Holdings (38)

PRAX PRAXIS PRECISION MEDICINES I 13.5%
Value ($000) $11,790 Shares 40,000 Est. Cost $186.22 Unrealized 0.0%
XERS XERIS BIOPHARMA HOLDINGS INC 7.2%
Value ($000) $6,280 Shares 800,000 Est. Cost $7.87 Unrealized 0.0%
BMRN BIOMARIN PHARMACEUTICAL INC 6.8%
Value ($000) $5,943 Shares 100,000 Est. Cost $54.44 Unrealized 0.0%
FOLD AMICUS THERAPEUTICS INC 5.9%
Value ($000) $5,126 Shares 360,000 Est. Cost $9.82 Unrealized 0.0%
ACAD ACADIA PHARMACEUTICALS INC 4.9%
Value ($000) $4,274 Shares 160,000 Est. Cost $23.90 Unrealized 0.0%
ANNX ANNEXON INC 4.3%
Value ($000) $3,765 Shares 750,000 Est. Cost $3.82 Unrealized 0.0%
NUVB NUVATION BIO INC 4.1%
Value ($000) $3,584 Shares 400,000 Est. Cost $6.19 Unrealized 0.0%
BBIO BRIDGEBIO PHARMA INC 3.1%
Value ($000) $2,754 Shares 36,000 Est. Cost $65.64 Unrealized 0.0%
PTCT PTC THERAPEUTICS INC 3.1%
Value ($000) $2,735 Shares 36,000 Est. Cost $72.67 Unrealized 0.0%
UTHR UNITED THERAPEUTICS CORP DEL 3.1%
Value ($000) $2,680 Shares 5,500 Est. Cost $465.69 Unrealized 0.0%
BCRX BIOCRYST PHARMACEUTICALS INC 2.7%
Value ($000) $2,340 Shares 300,000 Est. Cost $7.23 Unrealized 0.0%
PCVX VAXCYTE INC 2.6%
Value ($000) $2,307 Shares 50,000 Est. Cost $44.73 Unrealized 0.0%
GMAB GENMAB A/S 2.5%
Value ($000) $2,156 Shares 70,000 Est. Cost $30.80 Unrealized
SNDX SYNDAX PHARMACEUTICALS INC 2.4%
Value ($000) $2,101 Shares 100,000 Est. Cost $17.45 Unrealized 0.0%
VSTM VERASTEM INC 2.4%
Value ($000) $2,084 Shares 270,000 Est. Cost $8.91 Unrealized 0.0%
TARS TARSUS PHARMACEUTICALS INC 2.2%
Value ($000) $1,965 Shares 24,000 Est. Cost $74.67 Unrealized 0.0%
APOG APOGEE ENTERPRISES INC 2.2%
Value ($000) $1,887 Shares 25,000 Est. Cost $37.45 Unrealized 0.0%
ZNTL ZENTALIS PHARMACEUTICALS INC 2.0%
Value ($000) $1,782 Shares 1,320,000 Est. Cost $1.46 Unrealized 0.0%
INSM INSMED INC 2.0%
Value ($000) $1,740 Shares 10,000 Est. Cost $182.48 Unrealized 0.0%
CORT CORCEPT THERAPEUTICS INC 1.8%
Value ($000) $1,531 Shares 44,000 Est. Cost Unrealized
SLN SILENCE THERAPEUTICS PLC 1.7%
Value ($000) $1,459 Shares 240,000 Est. Cost $6.08 Unrealized
EWTX EDGEWISE THERAPEUTICS INC 1.6%
Value ($000) $1,439 Shares 58,000 Est. Cost $20.07 Unrealized 0.0%
BEAM BEAM THERAPEUTICS INC 1.6%
Value ($000) $1,386 Shares 50,000 Est. Cost $25.51 Unrealized 0.0%
ORIC ORIC PHARMACEUTICALS INC 1.5%
Value ($000) $1,309 Shares 160,000 Est. Cost $11.51 Unrealized 0.0%
APLS APELLIS PHARMACEUTICALS INC 1.4%
Value ($000) $1,256 Shares 50,000 Est. Cost $23.46 Unrealized 0.0%
DNLI DENALI THERAPEUTICS INC 1.3%
Value ($000) $1,156 Shares 70,000 Est. Cost $16.88 Unrealized 0.0%
RARE ULTRAGENYX PHARMACEUTICAL IN 1.3%
Value ($000) $1,150 Shares 50,000 Est. Cost $32.88 Unrealized 0.0%
ASND ASCENDIS PHARMA A/S 1.2%
Value ($000) $1,066 Shares 5,000 Est. Cost $213.24 Unrealized
NAMS NEWAMSTERDAM PHARMA COMPANY 1.2%
Value ($000) $1,052 Shares 30,000 Est. Cost $36.39 Unrealized 0.0%
LXRX LEXICON PHARMACEUTICALS INC 1.2%
Value ($000) $1,012 Shares 880,000 Est. Cost $1.37 Unrealized 0.0%
BHVN BIOHAVEN LTD 1.1%
Value ($000) $994 Shares 88,000 Est. Cost $12.39 Unrealized 0.0%
DNTH DIANTHUS THERAPEUTICS INC 1.1%
Value ($000) $989 Shares 24,000 Est. Cost $38.77 Unrealized 0.0%
NKTR NEKTAR THERAPEUTICS 1.0%
Value ($000) $846 Shares 20,000 Est. Cost $55.96 Unrealized 0.0%
IMTX IMMATICS N.V 1.0%
Value ($000) $840 Shares 80,000 Est. Cost $10.09 Unrealized 0.0%
AGIO AGIOS PHARMACEUTICALS INC 0.9%
Value ($000) $817 Shares 30,000 Est. Cost $35.08 Unrealized 0.0%
IMVT IMMUNOVANT INC 0.9%
Value ($000) $763 Shares 30,000 Est. Cost $22.30 Unrealized 0.0%
OLMA OLEMA PHARMACEUTICALS INC 0.9%
Value ($000) $750 Shares 30,000 Est. Cost $17.79 Unrealized 0.0%
ARQT ARCUTIS BIOTHERAPEUTICS INC 0.4%
Value ($000) $348 Shares 12,000 Est. Cost $25.60 Unrealized 0.0%